Ocular Therapeutix said on Tuesday its experimental eye disease drug was more effective in helping patients maintain their vision compared to Regeneron’s approved treatment… Reuters Health Information
Author: Medscape
New Rx Option for Neuromyelitis Optica Spectrum Disorder?
Phase 3 trial results suggest daratumumab, which is approved for multiple myeloma, may also be effective at reducing relapse risk in neuromyelitis optica spectrum disorder. Medscape Medical News
Metabolic Syndrome Tied to Glaucoma Risk
Metabolic syndrome, rather than BMI or waist circumference, is linked to an increased likelihood of glaucoma and may better identify adults who could benefit from closer eye screening. Medscape Medical News
Two Biologics Show Comparable Benefit in Uveitis
Adalimumab and tocilizumab perform similarly in controlling inflammation while reducing the use of corticosteroids at week 16 in patients with refractory, noninfectious uveitis. Medscape Medical News
Beyond Skin Deep: Biologics May Benefit Eyes in Psoriasis
In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis, and keratitis — but they do not consistently alleviate retinal disease. Medscape Medical News
Worsening Heart-Kidney-Metabolic Health May Threaten Vision
People with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular degeneration. Medscape Medical News
PRAME TCR Therapy Delivers Breakthrough in Uveal Melanoma
Dr Teresa Amaral reviews ESMO 2025 data showing unprecedented response rates with PRAME-directed TCR therapy in metastatic uveal melanoma. Medscape Oncology
Mary Tyler Moore Initiative Combats Diabetic Retinal Disease
Moore’s widower, S. Robert Levine, MD, launched the nonprofit in his famous wife’s memory to advance research and accelerate treatment. Medscape Medical News
FDA Approves First Dual-Agent Eye Drop for Presbyopia
The FDA has approved the first dual-agent eye drop to treat presbyopia, a condition that causes gradual loss of near vision in adults. Medscape Medical News
Novel Geographic Atrophy Measure Aligns With Vision Clarity
A novel measure of geographic atrophy shows a stronger correlation with vision loss than the area of the lesion and could aid in tracking functional decline. Medscape Medical News
Infographic: Physical Security at Work ‒ Do You Feel Safe?
Physicians surveyed by Medscape told how protected they feel from assaults and thefts at the medical offices or hospitals where they work. Medscape
Weight-Loss Drug Beats Lifestyle in Saving Eyes in Diabetes
Diabetes patients on tirzepatide have lower risks for new or worsening diabetic retinopathy, eye complications, and the need for eye treatments than those relying on lifestyle interventions alone. Medscape Medical News
ESMO 2025: CheckMate 238 Update Reinforces Nivolumab Benefit
Dr Teresa Amaral discusses the 9-year update on CheckMate 238 presented at ESMO 2025. Medscape Oncology
Vision May Worsen Soon After Optic Nerve Stroke
Vision often worsens early in nonarteritic anterior ischemic optic neuropathy, and a past episode in the other eye predicts the decline but common cardiovascular factors do not, a study finds. Medscape Medical News
Eye Trauma in Ball Sports: Pickleball Injuries On the Rise
Analysis of a US database shows rising pickleball-related eye injuries, mainly in older adults, with falls and orbital fractures relatively more common in pickleball than in other ball sports. Medscape Medical News
What’s Good for the Heart Can Also Prevent Blindness
New research suggests that asymptomatic patients with significant risk factors for cardiovascular disease may also need to see an ophthalmologist. Medscape Medical News
UK Glaucoma Cases Set to Rise 60% by 2060, Study Warns
More than one million people in the UK may already have glaucoma, with cases projected to rise sharply by 2060, increasing demand for eye care services. Press Association
FDA Makes Ianalumab Breakthrough for Sjögren Disease
Results from two clinical trials on ianalumab for Sjögren disease show favorable safety and adverse event outcomes, contributing to this designation. Medscape Medical News
FDA Makes Ianalumab a Breakthrough Therapy for Sjögren’s
Results from two clinical trials on ianalumab for Sjögren disease show favorable safety and adverse event outcomes, contributing to this designation. Medscape Medical News
As Private Equity Sells Out, Will Eye Practices Fare Better?
PE ownership of ophthalmology practices has reshaped physician opportunities and patient care. Will things change with publicly held companies buying them out? Medscape Medical News